US EditionChain Bridge Bancorp, Inc. Reports Second Quarter 2025 Financial Results
GLOBAL MARKETS INCLUDING CHINA AND EUROPE, JUL 29 – Volvo Cars highlights strong global demand for the EX30 Cross Country, with over 100,000 units sold by January 2025 despite market challenges, underscoring its competitive edge.
- On Monday, August 4, 2025, Volvo Cars will report its second quarter results after market close, and conduct a 5:00pm ET conference call.
- In collaboration with ECARX Holdings Inc., the Cloudpeak cross-domain software stack supported the global launch of the Volvo EX30 Cross Country compact electric SUV, starting in February 2025 and sales in China on July 17, 2025.
- In Shen’s words, ECARX’s Cloudpeak software demonstrates adaptability with scalable solutions automakers can quickly deploy, built through close collaboration.
- The Volvo EX30 Cross Country has generated over 100,000 units sold as of January 2025.
- This approach addresses a critical industry challenge as automakers seek to expand globally and meet diverse regulatory, ecosystem, and consumer preferences.
86 Articles
86 Articles
The Berkshire Eagle
MEXICO CITY, July 28, 2025 /PRNewswire/ -- FIBRA Prologis (BMV:FIBRAPL 14), a leading owner and operator of Class-A industrial real estate in Mexico, declared today a cash distribution of Ps. 1,117.2 million (US$60.2 million), or Ps. 0.6958 per Certificado Bursátil…
FIBRA Prologis Announces Second Quarter 2025 Earnings Results
MEXICO CITY, July 28, 2025 /PRNewswire/ -- FIBRA Prologis (BMV:FIBRAPL 14), a leading owner and operator of Class-A industrial real estate in Mexico, today reported results for the second quarter 2025.
MEXICO CITY, July 28, 2025 /PRNewswire-HISPANIC PR WIRE/ -- FIBRA Prologis (BMV:FIBRAPL 14), a leading real estate investment trust in the investment and management of Class-A industrial properties in Mexico, announced today its second quarter results.
Ekso Bionics Reports Second Quarter 2025 Financial Results
SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ('Ekso Bionics” or the 'Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and six months ended June 30, 2025.
Coverage Details
Bias Distribution
- 63% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
